You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
15 February 2021
Two applications to switch oral contraceptives from prescription-only to pharmacy (POM to P) status in the UK are now out for consultation. If they are approved, then Maxwellia’s Lovima and HRA Pharma’s Hana will become the country’s first OTC oral contraceptive pills.
11 February 2021
GlaxoSmithKline (GSK) Consumer Healthcare’s e-commerce sales increased by around 70% in 2020, according to chief executive officer Brian McNamara, who said e-commerce had been “strong across all categories”.
11 February 2021
GlaxoSmithKline (GSK) Consumer Healthcare’s integration of Pfizer Consumer Healthcare continues apace, according to chief executive officer Brian McNamara, who says the “commercial integration is now largely complete” and the “manufacturing integration is under way”.
11 February 2021
Worldwide sales at GlaxoSmithKline (GSK) Consumer Healthcare dropped by 7% at constant exchange rates to GBP2.36 billion (USD3.31 billion) in the fourth quarter of 2020 following the recent divestment programme.
11 February 2021
Prestige Consumer Healthcare highlighted e-commerce gains as it reported sales down by 0.9% to USD706 million in the nine months ended 31 December 2020.
11 February 2021
The global OTC market grew by 2.3% to USD130 billion at manufacturers’ selling prices in the 12 months ending 30 September 2020, according to the latest figures from IQVIA Consumer Health.
10 February 2021
Sanofi Consumer Healthcare plans to divest around 60% of its brands over the next two years, reducing its portfolio from more than 250 brands to roughly 100.
10 February 2021
Vitamins, minerals and supplements (VMS) specialist Nature’s Way has acquired full ownership of Baze, the US-based company that maintains “truly personalised nutrition starts with a blood test”.
10 February 2021
Sanofi Consumer Healthcare is “on track” with the key studies needed to switch Cialis (tadalafil) and Tamiflu (oseltamivir) from prescription-to-OTC status in the US, according to chief science officer Josephine Fubara.
10 February 2021
Sanofi's Consumer Healthcare business reported worldwide sales down by 3.0% in the fourth quarter of 2020, as social distancing and other measures to control the COVID-19 pandemic meant fewer people suffered from coughs, colds and flu.